Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent C. Difficile Infection”

45 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 45 results

Large-scale testing (Phase 3)Study completedNCT05831189
What this trial is testing

A Multi-center, Single-arm Trial Exploring the Safety and Clinical Effectiveness of RBX2660 Administered by Colonoscopy to Adults With Recurrent Clostridioides Difficile Infection

Who this might be right for
Clostridium Difficile Infection Recurrence
Ferring Pharmaceuticals 41
Not applicableStudy completedNCT02770326
What this trial is testing

Safety of Stool Transplant for Patients With Difficult to Treat C. Difficile Infection

Who this might be right for
C. Difficile InfectionCancer
Memorial Sloan Kettering Cancer Center 10
Testing effectiveness (Phase 2)Looking for participantsNCT07285213
What this trial is testing

Prevention of Recurrent C. Difficile Infection Study With AZD5148 Monoclonal Antibody

Who this might be right for
Clostridioides Difficile Infection
AstraZeneca 230
Not applicableLooking for participantsNCT07613645
What this trial is testing

Lifestyle and Recurrent Clostridioides Difficile Infection (CDI)

Who this might be right for
Clostridioides Difficile Infection
University of Michigan 20
Testing effectiveness (Phase 2)Study completedNCT02148601
What this trial is testing

Fecal Microbiota Transplantation by Colonoscopy for Recurrent C. Difficile Infection

Who this might be right for
Clostridium Difficile
Catholic University of the Sacred Heart 39
Large-scale testing (Phase 3)Ended earlyNCT02395848
What this trial is testing

Efficacy of 30-day Duration of Fidaxomicin for Recurrent C. Difficile Infection

Who this might be right for
Clostridium Difficile Infection
McMaster University 31
Testing effectiveness (Phase 2)Study completedNCT03497806
What this trial is testing

Open-Label Extension of CP101 Trials Evaluating Oral Full-Spectrum Microbiota™ (CP101) in Subjects With Recurrence of Clostridium Difficile Infection

Who this might be right for
Clostridium Difficile InfectionRecurrent Clostridium Difficile InfectionC. Diff+8 more
Finch Research and Development LLC. 132
Testing effectiveness (Phase 2)Study completedNCT02299570
What this trial is testing

Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection

Who this might be right for
Enterocolitis Clostridium Difficile Recurrent
Rebiotix Inc. 150
Large-scale testing (Phase 3)Ended earlyNCT03005379
What this trial is testing

Microbiota or Placebo After Antimicrobial Therapy for Recurrent C. Difficile at Home (MATCH)

Who this might be right for
Clostridium Difficile Infection
VA Office of Research and Development 153
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06948461
What this trial is testing

A Flexible Clinical Trial to Test if Freeze-dried Fecal Microbiota Therapy Helps Treat Diarrhea-predominant Irritable Bowel Syndrome or Prevent Recurring C. Difficile Infections.

Who this might be right for
Irritable Bowel Syndrome, Diarrhea-Predominant (IBS-D)Recurrent Clostridioides Difficile Infection (rCDI)Fecal Microbiota Therapy (FMT)+2 more
PharmaPlanter Technologies Inc 63
Early research (Phase 1)Study completedNCT02830542
What this trial is testing

SER-262 Versus Placebo in Adults With Primary Clostridium Difficile Infection to Prevent Recurrence

Who this might be right for
Clostridium Difficile Infection
Seres Therapeutics, Inc. 96
Large-scale testing (Phase 3)Ended earlyNCT05153499
What this trial is testing

A Trial of CP101 for the Prevention of Recurrent CDI (PRISM4)

Who this might be right for
Recurrent C. Difficile Infection
Finch Research and Development LLC. 19
Large-scale testing (Phase 3)Active Not RecruitingNCT05330182
What this trial is testing

LMN-201 for Prevention of C. Difficile Infection Recurrence

Who this might be right for
Clostridioides Difficile Infection
Lumen Bioscience, Inc. 375
Testing effectiveness (Phase 2)Study completedNCT03462459
What this trial is testing

Efficacy of Oral Vancomycin Prophylaxis for Prevention of Recurrent Clostridium Difficile Infection

Who this might be right for
Recurrent Clostridium Difficile InfectionClostridium Difficile InfectionCDI+3 more
University of Wisconsin, Madison 79
Large-scale testing (Phase 3)Looking for participantsNCT06979609
What this trial is testing

Secondary Prevention of Clostridioides Difficile Using Vancomycin

Who this might be right for
Clostridioides Difficile InfectionClostridioides Difficile Infection RecurrenceClostridoides Difficile Associated Disease
McGill University Health Centre/Research Institute of the McGill University Health Centre 300
Not applicableEnded earlyNCT05526807
What this trial is testing

Ursodeoxycholic Acid in C. Difficile Infection

Who this might be right for
Clostridioides Difficile Infection
Nottingham University Hospitals NHS Trust 6
Early research (Phase 1)Study completedNCT02865616
What this trial is testing

MET-2 Clinical Study for Recurrent Clostridium Difficile Infection (CDI)

Who this might be right for
Clostridium Difficile Infection
NuBiyota 19
Not applicableWithdrawnNCT05606159
What this trial is testing

Bacillus Velezensis DSM 33864 for Reduction of the Risk of Recurrent Clostridioides Difficile Infections

Who this might be right for
Clostridium Difficile Infection Recurrence
Novozymes A/S
Post-approval studies (Phase 4)Ended earlyNCT04626947
What this trial is testing

Prevention of Recurrent Clostridium Difficile Infection (CDI) in Patients With Inflammatory Bowel Disease (IBD).

Who this might be right for
Inflammatory Bowel DiseasesUlcerative ColitisCrohn Disease+1 more
David Binion, MD 19
Not applicableLooking for participantsNCT07250724
What this trial is testing

C. Difficile Toxin Levels in Stool From Healthy Individuals Following Standard of Care Antibiotic Treatment for CDI.

Who this might be right for
Clostridioides Difficile Infection Recurrence
Bactolife A/S 60
Next Page